Patients News | pharmaphorum

News

Safety concerns prompt Ipsen to pull Tazverik from market

Ipsen is voluntarily withdrawing its EZH2 inhibitor Tazverik from sale after a clinical trial suggested a link with secondary blood cancers.

News

Can GLP-1 drugs help tackle addiction?

New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.

News

UK puts £50m behind expanded clinical trials drive

The UK has awarded nearly £50m in funding for equipment to help the NHS carry out commercial clinical trials, with a focus on primary care capacity.

News

Loudspeaker used by a man, graphic art representation

'Dismal' survival demands change in bile duct cancer therapy

International cancer experts have called for big changes to bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

News

New FDA knockback hits uniQure and Huntington patients hard

uniQure looks like it may have to run another trial of its Huntington's disease gene therapy AMT-130, delaying the highly anticipated programme.

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

Safety concerns prompt Ipsen to pull Tazverik from market

Can GLP-1 drugs help tackle addiction?

UK puts £50m behind expanded clinical trials drive

'Dismal' survival demands change in bile duct cancer therapy

New FDA knockback hits uniQure and Huntington patients hard

NHS "isn't delivering equitable care for rare diseases"

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks